在先进的全身性巨细胞瘤症患者的日常临床实践中使用中素
Johannes Lübke1, Nicole Naumann1, Timo Brand1
1Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
对于先进的全身性巨细胞瘤 (AdvSM) 的中氨酸治疗显示出有利的安全性和持久的反应. 达到与改善整体存活相关的反应,突出了它在AdvSM患者中的有效性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 先进的全身性巨细胞瘤 (AdvSM) 是一种罕见的血液学疾病.
- 中素是一种已批准的多酶/KIT抑制剂,用于AdvSM治疗.
研究的目的:
- 评估AdvSM患者中素的剂量方案,安全性,疗效和整体存活期.
- 在现实环境中分析治疗结果和不良事件.
主要方法:
- 79名AdvSM患者的回顾性分析来自德国氨基和母细胞疾病登记册.
- 评估不同的中氨酸剂量方案及其对治疗结果的影响.
- 评估各种标准的不良事件,反应率和整体存活率.
主要成果:
- 中素表现出良好的安全性,可控不良事件,主要是恶心/和中性衰竭.
- 响应率根据标准有所不同:60% (修改Valent),29% (IWG-MRT-ECNM) 和13% (病理).
- 响应持续时间与改善的整体存活率有显著的相关性 (p < 0.001).
结论:
- 在不同的剂量方案中,中素在AdvSM患者中产生持久的反应和有利的安全概况.
- 治疗反应与改善整体存活率有关,支持中素在AdvSM管理中的作用.
- 停药综合征可以通过剂量逐渐减少和皮质类固醇桥梁来管理.
更多相关视频
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
10:44Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs that Stabilize Microtubules
Mitral Stenosis III: Medical Management
Treatment Resistant Cancers
